Company: REVB
Filing Date: 2025-03-06
Form Type: 10-K
Source: 0000950170-25-034584
Chunk: 326

Company: REVELATION BIOSCIENCES, INC.
Filing Date: 2025-03-06
Form: 10-K
Item: Item 8
Chunk 326
---
    Filed herewith.

    †
    Indicates a management contract or compensatory plan.

 85

Item 16. Form 10-K Summary.

Not applicable.

 86

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this Annual Report on Form 10-K to be signed on its behalf by the undersigned, thereunto duly authorized.

    REVELATION BIOSCIENCES, INC.

    Date: March 6, 2025
     
    By:
    /s/ James Rolke

    James Rolke

    Chief Executive Officer

    (principal executive officer)

KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Chester S. Zygmont, III and Joseph P. Galda, jointly and severally, their respective attorneys-in-fact, with the power of substitution, for each of them in any and all capacities, to sign any amendments to this Annual Report on Form 10-K and to file the same, with exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, hereby ratifying and confirming all that each of said attorneys-in-fact, or their respective substitute or substitutes, may do or cause to be done by virtue hereof.

 Pursuant to the requirements of the Securities Exchange Act of 1934, this Annual Report on Form 10-K has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated. 

     Date:  March 6, 2025
    By:
    /s/ James Rolke

    Chief Executive Officer and Director

     Date:  March 6, 2025
    By:
    /s/ George F.Tidmarsh, MD, PhD

    Chairman and Director

      Date:  March 6, 2025
    By:
    /s/ Chester S. Zygmont, III

    Chief Financial Officer and Principal Accounting Officer

      Date:  March 6, 2025
    By:
    /s/ Jennifer Carver

    Director

      Date:  March 6, 2025
    By:
    /s/ Jess Roper

    Director

      Date:  March 6, 2025
    By:
    /s/ Lakhmir Ch